Thomas Mohr

Title: Thomas Mohr: Innovator in Ocular and Prostate Health

Introduction

Thomas Mohr is a notable inventor based in Guntramsdorf, Austria. He has made significant contributions to the fields of ocular and prostate health through his innovative patents. With a total of 2 patents, Mohr's work focuses on the treatment and prevention of specific medical conditions.

Latest Patents

Mohr's latest patents include groundbreaking inventions aimed at addressing ocular diseases and benign prostatic hyperplasia. The first patent relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of ocular diseases related to neoangiogenesis. This includes conditions such as age-related macular degeneration (AMD) and choroidal neovascularization. The proteases used in this invention are selected from plant, non-mammalian animal, and microbial sources. The second patent focuses on a pharmaceutical preparation for treating benign prostatic hyperplasia. This invention also utilizes proteases and is designed for enteral administration, with specific dosage recommendations based on body weight.

Career Highlights

Throughout his career, Thomas Mohr has worked with reputable companies such as Volopharm GmbH and Marlyn Nutraceuticals Inc. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Mohr has collaborated with professionals like Lucia Desser and Bernhard Lotz, enhancing his research and development efforts in the medical field.

Conclusion

Thomas Mohr's contributions to ocular and prostate health through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly impact patient care and treatment options.